New York (HedgeCo.Net) – One World Cannabis Ltd., a subsidiary of Israel-based developer of cannabinoid-based therapies, OWC Pharmaceutical Research Corp., is presenting at the WALL ST. Conference (WSC) in Miami, Florida today.
“We are excited to be presenting to such high profile and experienced professionals with the deep vision of the future of Medical Cannabis,” said One World Cannabis CEO Ziv Turner. “I am absolutely sure that our business structure, activities, focus on new medical cannabis products and international regulation will be most appealing to such professionals.”
Dr. Alan Shackelford, the Company’s Chief Science Officer was invited to be a keynote speaker, and will be discussing the company’s innovative approach to using cannabinoid-based therapies to treat Multiple Myeloma and other indications. Ziv Turner, the Company’s Chief Executive Officer will provide a high-level overview of the Company.
Industry leaders from the hedge fund, investment banking, and private equity are slated to attend this year’s conference, which focuses on the micro-cap and venture capital arena.
Alex Akesson
Editor for HedgeCo.net
alex@hedgeco.net
HedgeCo.Net is a premier hedge fund database and community for qualified and accredited investors only. Membership in HedgeCo.net is FREE and EASY. We also offer FREE LISTINGS for Hedge Funds!
&nb
